Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Xenoview Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Dose Delivery Bag (1000mL)—50 (w. attachable mouthpieces and affixable dose labels)
Manufacturer
Generic Availability
NO
Xenoview Indications
Indications
For use with MRI for evaluation of lung ventilation in adults and pediatric patients.
Limitations of Use
Not for use with lung perfusion imaging.
Xenoview Dosage and Administration
Adult
See full labeling. Measure volume and Dose Equivalent (DE) in the dose delivery bag using the HPX Polarization Measurement Station no more than 5mins prior to administration. Inhale the full dose and hold for up to 15secs during MR image acquisition; may repeat with a new dose if image quality is insufficient. ≥12yrs: 75–100mL DE of the entire contents of 1 dose delivery bag; DE of >100mL is acceptable. DE = (total volume xenon gas [250–750mL]) x (fraction of xenon Xe 129 isotopic enrichment in the xenon gas [>80%]) x (fraction of hyperpolarization [mean fraction 38–54% at the completion of polarization of 250mL of xenon gas]).
Children
<12yrs: not indicated.
Xenoview Contraindications
Not Applicable
Xenoview Boxed Warnings
Not Applicable
Xenoview Warnings/Precautions
Warnings/Precautions
Risk of decreased image quality from supplemental oxygen. Transient hypoxia. Monitor all patients for oxygen desaturation and symptoms of hypoxemia; treat as clinically indicated. Pregnancy. Nursing mothers.
Xenoview Pharmacokinetics
Elimination
Half-life: 14.5 seconds for a 75% Xe/25% N2 gas mixture; 14.3 seconds for a 25% Xe/75% N2 gas mixture.
Xenoview Interactions
Not Applicable
Xenoview Adverse Reactions
Adverse Reactions
Oropharyngeal pain, headache, dizziness.
Xenoview Clinical Trials
See Literature
Xenoview Note
Not Applicable
Xenoview Patient Counseling
See Literature
